Adenomatous Polyp Clinical Trial
Official title:
A Multicenter, Prospective, Randomized Controlled Trial for the Detection of Colon Polyps and Predicting Histology
In this study the investigators hypothesize that High Definition White Light colonoscopy and
narrow band imaging (NBI) will detect a higher number of adenomas compared to standard
definition white light colonoscopy. NBI will have a higher accuracy in predicting polyp
histology compared to high definition colonoscopy and standard colonoscopy.
Specific Aim 1 - To compare the prevalence of adenomas detected by standard colonoscopy,
high-definition white light colonoscopy and NBI.
Specific Aim 2 - To compare the number of adenoma detected per subject by standard
colonoscopy, high-definition white light colonoscopy and NBI.
Specific Aim 3 - To compare the accuracy of predicting polyp histology between standard
colonoscopy, high-definition white light colonoscopy and NBI by evaluating the surface
mucosal and vascular patterns during the procedure.
Specific Aim 4 - To determine the inter-observer agreement between investigators for the
recognition of various polyp patterns
This study is a multi-center randomized controlled trial that will be conducted at the
Kansas City VA Medical Center, Kansas City, MO and The Barnes Jewish Hospital, St Louis, MO.
Patients referred for screening and surveillance colonoscopy will be enrolled. They will be
randomized to one of the following three groups: standard white light colonoscopy,
high-definition white light colonoscopy or NBI.
All colonoscopies will be performed at the Kansas City VA Medical Center and The Barnes
Jewish Hospital, St Louis, MO. Moderate sedation will be administered for the procedure with
intravenous midazolam, demerol or fentanyl and Propofol. In patients randomized to the NBI
arm, the colonoscope will be inserted to the cecum under white light and will switch to NBI
mode at the time of withdrawal. After cecal intubation, the colonic mucosa will be carefully
visualized during withdrawal of the scope with one of the three imaging modalities to which
the patient has been randomized. No effort will be made to look for polyps during the
insertion of the colonoscope. All polyps detected will be documented for their size,
morphology (Polypoid: sessile, pedunculated or Non polypoid: superficially elevated,
completely flat, depressed), and location. The surface of the polyp will be assessed during
the procedure and the histology will be predicted real time by evaluating the surface
mucosal and vascular patterns. The patterns would be classified into one of the four
patterns described in our pilot study (tubular and gyrus patterns will be combined to
tubulogyrus pattern). Any other patterns detected would be described and kept in the
miscellaneous category. If a pattern is not identified on a polyp with either white light or
NBI, it will be recorded as such and no attempts will be made to predict histology. Photo
documentation of the surface patterns of the polyps will be performed. Polyps will then be
removed either with a biopsy forcep or snare and sent for histopathological evaluation. Each
polyp removed will have one or more corresponding picture of its surface patterns and these
will be labeled accordingly. The total time spent in inspecting the colonic mucosa
(excluding the time spent in removal of polyps or clearing the colon of liquid and solid
debris) will be measured with a stop watch. Representative images of the various polyp
patterns will be reviewed, discussed and standardized amongst all the investigators at both
sites. In addition, images of all the polyp patterns will be printed and posted in the
endoscopy suites at both hospitals.
The bowel preparation will be evaluated and graded as follow:
Excellent (score=1) - >90% mucosa seen, mostly liquid colonic contents, minimal suctioning
needed for adequate visualization.
Good (score=2) - >90% of mucosa seen, mostly liquid colonic contents, significant suctioning
needed for adequate visualization Fair (score=3) - > 90% mucosa seen, mixture of liquid and
semisolid colonic contents, could be suctioned and/or washed Inadequate (score=4) - <90%
mucosa seen, mixture of semisolid ands solid colonic contents, which could not be suctioned
or washed
Patients with "Inadequate" (score = 4) bowel prep will be excluded.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00828984 -
Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer
|
Phase 2 | |
Completed |
NCT01675752 -
Small Hyperplastic and Adenomatous Reliability Protocol
|
N/A | |
Completed |
NCT01656746 -
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
|
N/A | |
Completed |
NCT01124266 -
Endoscopy Nurse Participation in Adenoma Detection Rate During Colonoscopy
|
Phase 4 | |
Completed |
NCT01133041 -
Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps
|
Phase 4 | |
Completed |
NCT01312467 -
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
|
Phase 2 | |
Completed |
NCT00754494 -
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
|
Phase 2 | |
Completed |
NCT00983580 -
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT00613262 -
A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging
|
N/A |